4//SEC Filing
Rodino-Klapac Louise 4
Accession 0000950170-25-032759
CIK 0000873303other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:00 PM ET
Size
5.2 KB
Accession
0000950170-25-032759
Insider Transaction Report
Form 4
Rodino-Klapac Louise
Head of R&D, CSO
Transactions
- Tax Payment
Common Stock
2025-03-03$103.77/sh−715$74,196→ 67,026 total
Footnotes (2)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
- [F2]Amount of Securities Beneficially Owned includes 111 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001836218
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:00 PM ET
- Size
- 5.2 KB